COSMO Pharmaceuticals (Switzerland) Analysis
| COPN Stock | CHF 62.40 0.20 0.32% |
COSMO Pharmaceuticals SA is overvalued with Real Value of 56.16 and Hype Value of 62.4. The main objective of COSMO Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what COSMO Pharmaceuticals SA is worth, separate from its market price. There are two main types of COSMO Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect COSMO Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of COSMO Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The COSMO Pharmaceuticals stock is traded in Switzerland on SIX Swiss Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Switzerland. COSMO Pharmaceuticals is usually not traded on National Day, Christmas Day, St . Stephen 's Day, New Year 's Day, Berchtoldstag, Good Friday, Easter Monday, International Workers ' Day. COSMO Stock trading window is adjusted to Europe/Zurich timezone.
COSMO |
COSMO Stock Analysis Notes
About 47.0% of the company shares are held by company insiders. The book value of COSMO Pharmaceuticals was currently reported as 28.23. The company last dividend was issued on the 1st of June 2022. Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. COSMO PHARM operates under Drug Manufacturers - Major classification in Switzerland and is traded on Switzerland Exchange. It employs 306 people. For more info on COSMO Pharmaceuticals SA please contact Alessandro LLM at 353 1 817 0370 or go to https://www.cosmopharma.com.COSMO Pharmaceuticals Investment Alerts
| COSMO Pharmaceuticals generated a negative expected return over the last 90 days | |
| About 47.0% of the company shares are held by company insiders |
COSMO Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate COSMO Pharmaceuticals's market, we take the total number of its shares issued and multiply it by COSMO Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.COSMO Profitablity
COSMO Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase COSMO Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, COSMO Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, COSMO Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of COSMO Pharmaceuticals' profitability requires more research than a typical breakdown of COSMO Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.45 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25. Technical Drivers
As of the 4th of December, COSMO Pharmaceuticals shows the mean deviation of 0.7735, and Risk Adjusted Performance of (0.29). COSMO Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm COSMO Pharmaceuticals mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if COSMO Pharmaceuticals is priced some-what accurately, providing market reflects its regular price of 62.4 per share.COSMO Pharmaceuticals Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. COSMO Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for COSMO Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
COSMO Pharmaceuticals Outstanding Bonds
COSMO Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. COSMO Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most COSMO bonds can be classified according to their maturity, which is the date when COSMO Pharmaceuticals SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
COSMO Pharmaceuticals Predictive Daily Indicators
COSMO Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of COSMO Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
COSMO Pharmaceuticals Forecast Models
COSMO Pharmaceuticals' time-series forecasting models are one of many COSMO Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary COSMO Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About COSMO Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how COSMO Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling COSMO shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as COSMO Pharmaceuticals. By using and applying COSMO Stock analysis, traders can create a robust methodology for identifying COSMO entry and exit points for their positions.
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. COSMO PHARM operates under Drug Manufacturers - Major classification in Switzerland and is traded on Switzerland Exchange. It employs 306 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding COSMO Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Additional Tools for COSMO Stock Analysis
When running COSMO Pharmaceuticals' price analysis, check to measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.